Welcome to AHRMM's Knowledge Center. Find all the resources you’re looking for by applying filters for precise and efficient search functionality.
21 results returned
October 19, 2016 | Content Areas: Finance | Tags: Analytics, Change Management, Cost Management, CQO, Inventory Management | Formats: White Paper
To develop larger savings opportunities, supply chain must expand the use of supply utilization analysis and alignment. This requires effectively and collaboratively using real-time, granular usage data, acquired through electronic technology such as barcode and Radio-Frequency Identification (RFID). Understanding and engaging Millennials’ unique attitudes and capabilities, especially their technology orientation, and successfully integrating these with Baby Boomer attributes, will enable supply chain to leverage the new workforce culture through the increased use of electronic technology to shift the cost savings paradigm to supply utilization alignment. Through this synergy, supply chain can drive significant savings to help their facilities weather the perfect storm of declining revenues and increasing costs.
AHRMM is one of the representatives on the Medical Device Innovation Consortium (MDIC) Product Quality Outcomes Analytics project team; a multi-disciplinary group comprised of representatives from manufacturers, providers, FDA, and Value Analysis Committees (VACs). The team's objectives are to provide information about the feasibility and effectiveness of using publicly available data and to recommend analytic techniques to enable assessments of medical device product quality. This report is a summary of the team’s observations and recommendations for the development of a formal approach to measure medical device product quality outcomes in order to provide feedback and reward the market for Quality. Recommendations included the need to improve data robustness as well as the need to develop an operating model that would enable data access and transparency for scale and sustainability in the future.
July 07, 2016 | Content Areas: Strategic Planning | Tags: Cost Management, Pharmacy, Regulatory | Formats: White Paper
The purpose of this white paper is to prepare Supply Chain professionals to better understand how to support navigating some of the risks and opportunities inherent in participating in the 340B Drug Discount Program. Pharmacy and Finance need to be most familiar with the details of participation and compliancy, but Supply Chain professionals are also increasingly being expected to support an organization’s engagement in the program. This increased expectation is arising not only from growing responsibility for Pharmacy’s Supply Chain, but also due to products that Supply Chain may be ordering or managing that need to be accounted for under the program in order to remain compliant.
February 09, 2016 | Content Areas: Procurement | Tags: Data Standards, Regulatory, UDI | Formats: Advisory/Briefing/Update
The AHRMM Issues & Legislative committee released an Awareness Brief providing a quick reference to the Draft Guidance for UDI Convenience Kits, released by the FDA in January 2016. The draft guidance defines the term “convenience kit” for purposes of compliance with UDI labeling and data submission requirements only.
October 27, 2015 | Content Areas: Value Analysis | Tags: Analytics, Clinical Resource Management, CQO, Regulatory | Formats: On-Demand Recording | CPE Credit: 2
This two-part on-demand webinar series focuses on several areas of infection prevention including value analysis of regulatory aspects and applications to meet regulations and requirements. You can purchase each on-demand webinar individually or as the bundle to save.
The Regulatory Aspects of Infection Prevention and Control: A Value Analysis Perspective
This product is also available as a bundle. View BundleOctober 13, 2015 | Content Areas: Value Analysis | Tags: Analytics, Clinical Resource Management, CQO, Regulatory | Formats: On-Demand Recording | CPE Credit: 1
Supply chain and value analysis professionals play a unique and critical role in reducing infections through proper product analysis, evaluation, and implementation across the entire healthcare delivery system.